Those with Type 2 diabetes have a new, revolutionary defense against the damage the disease does to the kidneys. The drug is named canagliflozin and is seen as a major improvement over an
existing therapy, two decades old, designed to
Those with Type 2 diabetes have a new, revolutionary defense against the damage the disease does to the kidneys. The drug is named canagliflozin and is seen as a major improvement over an
existing therapy, two decades old, designed to
